CABANA Trial: Ablation vs Drugs for Atrial Fibrillation, Amyloid PET for MCI or Dementia, Review of Cerebral Intraparenchymal Hemorrhage, and more

JAMA Editor’s Summary

CABANA Trial: Ablation vs Drugs for Atrial Fibrillation, Amyloid PET for MCI or Dementia, Review of Cerebral Intraparenchymal Hemorrhage, and more

Editor's Summary by Mary McDermott, MD, Senior Editor in Chief of JAMA, the Journal of the American Medical Association, for the

April 2, 2019

Listen on your favorite player Take me to this show’s page

ADVERTISEMENT

Newer →

Effect of Vitamin D on GI Cancer Survival, HIV PrEP and STIs, Tumor Genomics and NSCLC Outcomes, and more

← Older

Respiratory Support for Preterm Infants, Intramyocardial Mesenchymal Precursor Cells for Heart Failure, Review of In-Hospital Cardiac Arrest, and more

Facebook Twitter Buffer LinkedIn WhatsApp

CABANA Trial: Ablation vs Drugs for Atrial Fibrillation, Amyloid PET for MCI or Dementia, Review of Cerebral Intraparenchymal Hemorrhage, and more

Editor’s Summary by Mary McDermott, MD, Senior Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 02, 2019 issue

ADVERTISEMENT

Submit Your Event

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Silver Sponsors

Bronze Sponsors

Event and Media Partners

00:00

00:00